[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Page 19735]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-0148]


International Drug Scheduling; Convention on Psychotropic 
Substances; Dihydroetorphine, Ephedrine, and Remifentanil; Isomers of 
Psychotropic Substances

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is correcting a notice that 
appeared in the Federal Register of March 18, 1998 (63 FR 13258). The 
document announced an upcoming World Health Organization review of 
three substances. The document was published with an error. This 
document corrects that error.

FOR FURTHER INFORMATION CONTACT: Nicholas P. Reuter, Office of Health 
Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1696, E-mail: NR[email protected].

    In FR Doc. 98-6910, beginning on page 13258 in the Federal Register 
of Wednesday, March 18, 1998, the following correction is made:
    1. On page 13259, in the first column, in the fourth full 
paragraph, the second sentence ``Remifentanil is approved in the United 
States as an anesthetic for use in animals and is controlled 
domestically as a narcotic in schedule II of the CSA.'' is corrected to 
read as follows: ``Remifentanil is approved in the United States as an 
anesthetic and is controlled domestically as a narcotic in schedule II 
of the CSA.''

    Dated: April 14, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-10404 Filed 4-20-98; 8:45 am]
BILLING CODE 4160-01-F